Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Clinical potential of antibody–drug conjugates in early-phase clinical trials for late-line treatment of advanced solid tumors
Ippei Miyamoto
Takahiro Kogawa
Kana Kurokawa
Eriko Miyawaki
Yohei Arihara
Shota Fukuoka
Yukinori Ozaki
Makiko Ono
Mayu Yunokawa
Masumi Yamazaki
Naomi Hayashi
Ippei Fukada
Takayuki Ueno
Shunji Takahashi
Shigehisa Kitano
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1007/s10637-025-01576-x
Aug 22, 2025
Version published to 10.21203/rs.3.rs-6954090/v1 on Research Square
Jul 2, 2025
Related articles
Circulating tumour DNA-guided second-line targeted therapy for patients with metastatic colorectal cancer after failure of first-line cetuximab-based treatment: A prospective, phase II trial
This article has 14 authors:
Jianling Zou
Wentao Yang
Yingying Liu
Wenhua Li
Jieyun Zhang
Qirong Geng
Jinjia Chang
Xiaolin Zhu
Mingzhu Huang
Chenchen Wang
Xin Hu
Xiaodong Zhu
Weijian Guo
Zhiyu Chen
Clinical prognosis factor of ramucirumab monotherapy for advanced gastric cancer
This article has 9 authors:
Yoshinori Kikuchi
Sakae Nagaoka
Nobue Futawatari
Muneharu Fujisaki
Hidejiro Urakami
Mao Tsuru
Satoshi Yajima
Yoko Oshima
Hideaki Shimada
Post-Progression Immunotherapy and Prognostic Factors in HER2-Negative Advanced Gastric Cancer: A Retrospective Analysis of 118 Cases
This article has 9 authors:
Zhirun Cai
Shusheng Wu
Haoyu Wang
Xudong Liu
Wenxi Dang
Zhihua Zhang
Wen Li
Mengge Li
Yifu He
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up